These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 19462936
1. Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time. Olteanu H, Downes KA, Patel J, Praprotnik D, Sarode R. Clin Lab; 2009; 55(3-4):138-42. PubMed ID: 19462936 [Abstract] [Full Text] [Related]
2. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy. Jouhikainen T. Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242 [Abstract] [Full Text] [Related]
3. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests. Galli M, Dlott J, Norbis F, Ruggeri L, Cler L, Triplett DA, Barbui T. Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107 [Abstract] [Full Text] [Related]
4. [Detection of lupus anticoagulant using a modified diluted Russell's viper venom time test]. Sato K, Kagami K, Asai M, Nakashima N, Takamatsu J. Rinsho Byori; 1995 Mar; 43(3):263-8. PubMed ID: 7745832 [Abstract] [Full Text] [Related]
5. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity. Moore GW, Peyrafitte M, Dunois C, Amiral J. Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386 [Abstract] [Full Text] [Related]
6. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism. Morelli VM, Rodrigues CA, Noguti MA, Matos MF, da Silveira RC, Ribeiro AA, Lourenço DM. Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313 [Abstract] [Full Text] [Related]
7. Factor X and factor II activity levels do not always agree in warfarin-treated lupus anticoagulant patients. Rosborough TK, Jacobsen JM, Shepherd MF. Blood Coagul Fibrinolysis; 2010 Apr; 21(3):242-4. PubMed ID: 20182349 [Abstract] [Full Text] [Related]
8. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Della Valle P, Crippa L, Garlando AM, Pattarini E, Safa O, Viganò D'Angelo S, D'Angelo A. Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206 [Abstract] [Full Text] [Related]
9. [Usefulness of silica clotting time for detection of lupus anticoagulants]. Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI. Korean J Lab Med; 2009 Dec; 29(6):497-504. PubMed ID: 20046079 [Abstract] [Full Text] [Related]
17. Further evidence of false negative screening for lupus anticoagulants. Moore GW, Henley A, Greenwood CK, Rangarajan S. Thromb Res; 2008 Sep; 121(4):477-84. PubMed ID: 17602725 [Abstract] [Full Text] [Related]
18. Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer. Shirts BH, Rodgers GM, Smock KJ. Thromb Res; 2012 Sep; 130(3):e134-8. PubMed ID: 22542363 [Abstract] [Full Text] [Related]